IAV NA (K432) Specific Neutra™ Antibody (V3S-0923-XY40), Human IgG (CAT#: V3S-0923-XY40)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human neutralizing antibody binding IAV NA, termed Z2B3. It exhibited cross-reactivity to both N9 and a broad range of seasonal and avian N1 proteins. It is capable of neutralizing multiple influenza virus. This antibody has been determined by Enzyme-linked immunosorbent assay, Surface plasmon resonance, Inhibition assay and Neutralization assay.
Clonality Monoclonal
Host Species Human
Target Species IAV (N1, N9)
Cross Reactivity 18N1, AH-N9, H1N1 (A/California/07/2009 and A/Puerto Rico/8/1934), H5N1 (A/Vietnam/1194/2004), H7N9 (A/Anhui/1/2013)
Epitope The antibody Z2B3 recognizes seven of the eight conserved catalytic residues (except E276) and some of the frame residues (including W178, S179, I222, and E227) as its epitope in 18N1. The clone is sensitive to N1 NA with a K432E substitution.
IC50 Inhibition of viral replication:
1.432 μg/ml (A/California/07/2009 (H1N1))
5.202 μg/ml (A/Puerto Rico/8/1934 (H1N1))
123.7 μg/ml (A/Serbia/NS-601/2014 (H1N1))
7.883 μg/ml (A/Vietnam/1194/2004 (H5N1))
27.27 μg/ml (A/Anhui/1/2013 (H7N9))
Inhibition of enzymatic activity:
30.41 nM (A/California/07/2009 (H1N1))
33.07 nM (A/Puerto Rico/8/1934 (H1N1))
>2,000 nM (A/Serbia/NS-601/2014 (H1N1))
69.73 nM (A/Vietnam/1194/2004 (H5N1))
101.3 nM (A/Anhui/1/2013 (H7N9))
Affinity 543 nM
Isotype Human IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; SPR; Neut; Inhib
Application Notes Surface plasmon resonance (SPR): Two-fold serial dilutions of antibody was prepared and sequentially injected at a flow rate of 30 μL/min for 60 s.
Inhibition assay (Inhib): Two-fold serially diluted MAb was mixed with an equal volume of 100 TCID50 virus for 1 h at 37°C.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target IAV NA
Alternative Name Neuraminidase
Research Area Infectious Disease
Related Disease Influenza
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry